Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Inactivated Influenza A/H5N1 Vaccine With or Without Adjuvants in Healthy Adults
NCT00280033Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Feb 2006
- Primary completion
- Nov 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Inactivated Influenza A/H5N1 Vaccine in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Feb 2006; status: completed.
02
Drugs
Inactivated Influenza A/H5N1 Vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00280033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00280033.